TABLE OF CONTENTS FIGURES AND TABLES PART 1. INTRODUCTION 1.1 Description 1.2 Objectives of The Study 1.3 Market Segment 1.4 Years Considered for The Report 1.5 Currency 1.6 Key Target Audience PART 2. RESEARCH METHODOLOGY 2.1 Primary Research 2.2 Secondary Research PART 3. EXECUTIVE SUMMARY PART 4. MARKET OVERVIEW 4.1 Introduction 4.2 Drivers 4.3 Restraints PART 5. GLOBAL AUTO-INJECTORS MARKET BY PRODUCT TYPE 5.1 Disposable autoinjectors 5.2 Reusable autoinjectors PART 6. GLOBAL AUTO-INJECTORS MARKET BY ROUTE OF ADMINISTRATION 6.1 Intramuscular 6.2 Subcutaneous PART 7. GLOBAL AUTO-INJECTORS MARKET BY THERAPY 7.1 Anaphylaxis 7.2 Diabetes 7.3 Multiple sclerosis 7.4 Rheumatoid arthritis 7.5 Others PART 8. GLOBAL AUTO-INJECTORS MARKET BY END USER 8.1 Ambulatory care 8.2 Home care settings 8.3 Hospitals and clinics PART 9. GLOBAL AUTO-INJECTORS MARKET BY GEOGRAPHY 9.1 North America 9.2 Europe 9.3 Asia-Pacific 9.4 Latin America 9.5 Middle East & Africa PART 10. COMPANY PROFILES 10.1 Abbvie Inc. 10.2 Amgen Inc. 10.3 Antares Pharma, Inc. (Halozyme Therapeutics, Inc.) 10.4 Becton Dickinson and Co. 10.5 Eli Lilly and Company 10.6 GSK plc 10.7 Johnson & Johnson 10.8 Merck KGaA 10.9 Novartis AG 10.10 SHL Medical AG 10.11 Teva Pharmaceutical Industries Ltd. 10.12 Ypsomed AG DISCLAIMER